We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6993:HKEXBlue Moon Group Holdings Ltd. Analysis

Data as of 2026-05-25 - not real-time

HK$3.13

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Blue Moon Group is trading just above its short‑term moving average, suggesting a slight short‑term price edge. The 14‑day RSI sits in a mid‑range level, indicating neutral momentum. However, the MACD histogram is negative and the signal line is bearish, flagging downward momentum that could curb further gains. Volatility over the past month is well above typical levels, implying sizable price swings. The stock offers a high dividend yield that ranks among the higher peers in the consumer‑defensive space, yet the payout ratio is well above 100%, raising questions about sustainability. On the fundamentals side, the company posted a loss per share and negative operating cash flow, while the forward price‑to‑earnings multiple remains relatively high, pointing to an overvalued valuation.
The defensive household and personal‑products sector typically shields earnings from cyclical shocks, so sector risk is modest. Nevertheless, exposure to the Chinese market introduces medium‑level geographic and regulatory considerations. With a low beta, the stock is less sensitive to overall market moves, but its high price volatility and thin liquidity at support levels keep the risk profile elevated. In the short run, bearish technical signals and the unsustainable dividend policy suggest a cautious stance. Medium‑term investors should monitor cash‑flow trends and any strategic moves to improve margins before committing capital. Over the longer horizon, a successful turnaround could unlock value, but the current risk‑reward balance favors a hold rather than an aggressive buy.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD momentum
  • Elevated price volatility
  • Proximity to short‑term resistance

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Negative earnings and cash‑flow
  • Unsustainable dividend payout
  • Overvalued forward multiples

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Defensive sector demand
  • Potential turnaround in profitability
  • High cash reserves offsetting modest debt

Key Metrics & Analysis

Financial Health

Revenue Growth-1.00%
Profit Margin-3.91%
P/E Ratio28.5
ROE-4.06%
ROA-2.64%
Debt/Equity1.13
P/B Ratio2.4
Op. Cash FlowHK$-351947008
Free Cash FlowHK$-516152384

Technical Analysis

TrendNeutral
RSI56.4
SupportHK$2.94
ResistanceHK$3.20
MA 20HK$3.09
MA 50HK$2.93
MA 200HK$3.04
MACDBearish
VolumeIncreasing
Fear & Greed Index91.75

Valuation

Target PriceHK$2.62
Upside/Downside-16.29%
GradeOvervalued
TypeValue
Dividend Yield3.19%

Risk Assessment

Beta0.35
Volatility31.60%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.